Depomed settles with generics over Gralise dispute

16-04-2014

Depomed settles with generics over Gralise dispute

Photo: Valentina Razumova / Shutterstock.com

Depomed, a California-based pharmaceutical company, has settled litigation with two of three companies that sought to launch generic versions of its Gralise (gabapentin) product before patents covering it expire.


Depomed, settlement, Gralise, Incepta, Zydus, patent

LSIPR